Literature DB >> 26362529

Clinical effect of azithromycin as an adjunct to non-surgical treatment of chronic periodontitis: a meta-analysis of randomized controlled clinical trials.

Z Zhang1, Y Zheng2, X Bian3.   

Abstract

The results of recent published studies focusing on the effect of azithromycin as an adjunct to scaling and root planing (SRP) in the treatment of chronic periodontitis are inconsistent. We conducted a meta-analysis of randomized controlled clinical trials to examine the effect of azithromycin combined with SRP on periodontal clinical parameters as compared to SRP alone. An electronic search was carried out on Pubmed, Embase and the Cochrane Central Register of Controlled Trials from their earliest records through December 28, 2014 to identify studies that met pre-stated inclusion criteria. Reference lists of retrieved articles were also reviewed. Data were extracted independently by two authors. Either a fixed- or random-effects model was used to calculate the overall effect sizes of azithromycin on probing depth, attachment level (AL) and bleeding on probing (BOP). Heterogeneity was evaluated using the Q test and I(2) statistic. Publication bias was evaluated by Begg's test and Egger's test. A total of 14 trials were included in the meta-analysis. Compared with SRP alone, locally delivered azithromycin plus SRP statistically significantly reduced probing depth by 0.99 mm (95% CI 0.42-1.57) and increased AL by 1.12 mm (95% CI 0.31-1.92). In addition, systemically administered azithromycin plus SRP statistically significantly reduced probing depth by 0.21 mm (95% CI 0.12-0.29), BOP by 4.50% (95% CI 1.45-7.56) and increased AL by 0.23 mm (95% CI 0.07-0.39). Sensitivity analysis yielded similar results. No evidence of publication bias was observed. The additional benefit of systemic azithromycin was shown at the initially deep probing depth sites, but not at shallow or moderate sites. The overall effect sizes of systemic azithromycin showed a tendency to decrease with time, and meta-regression analysis suggested a negative relation between the length of follow-up and net change in probing depth (r = -0.05, p = 0.02). This meta-analysis provides further evidence that azithromycin used as an adjunct to SRP significantly improves the efficacy of non-surgical periodontal therapy on reducing probing depth, BOP and improving AL, particularly at the initially deep probing depth sites.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  azithromycin; meta-analysis; periodontitis; root planing

Mesh:

Substances:

Year:  2015        PMID: 26362529     DOI: 10.1111/jre.12319

Source DB:  PubMed          Journal:  J Periodontal Res        ISSN: 0022-3484            Impact factor:   4.419


  8 in total

1.  Disease severity, debridement approach and timing of drug modify outcomes of adjunctive azithromycin in non-surgical management of chronic periodontitis: a multivariate meta-analysis.

Authors:  Nithya Jagannathan; Aneesha Acharya; Ong Yi Farn; Kar Yan Li; Luigi Nibali; George Pelekos
Journal:  BMC Oral Health       Date:  2019-04-27       Impact factor: 2.757

2.  Association of periodontal therapy, with inflammatory biomarkers and complications in COVID-19 patients: a case control study.

Authors:  Khalid N Said; Ahmed M Al-Momani; Jassim A Almaseeh; Nadya Marouf; Amer Shatta; Jassim Al-Abdulla; Sahar Alaji; Hanin Daas; Shailaja S Tharupeedikayil; Venkateswara Rao Chinta; Ali Ait Hssain; Mohammad Abusamak; Shiraz Salih; Noha Barhom; Wenji Cai; Mariano Sanz; Faleh Tamimi
Journal:  Clin Oral Investig       Date:  2022-07-29       Impact factor: 3.606

3.  A Rare Case of Metronidazole Overdose Causing Ventricular Fibrillation.

Authors:  Mohamed Abdelgadir M Elgassim; Amin Saied Sanosi Saied; Moayad A Mustafa; Amro Abdelrahman; Ibtesam AlJaufi; Waleed Salem
Journal:  Cureus       Date:  2022-05-04

4.  Clinical effects of probiotic or azithromycin as an adjunct to scaling and root planning in the treatment of stage III periodontitis: a pilot randomized controlled clinical trial.

Authors:  Alicia Morales; Rafael Contador; Joel Bravo; Paola Carvajal; Nora Silva; Franz-Josef Strauss; Jorge Gamonal
Journal:  BMC Oral Health       Date:  2021-01-07       Impact factor: 2.757

Review 5.  Comparing the Antimicrobial In Vitro Efficacy of Amoxicillin/Metronidazole against Azithromycin-A Systematic Review.

Authors:  Manuela Kaufmann; Patrik Lenherr; Clemens Walter; Thomas Thurnheer; Thomas Attin; Daniel B Wiedemeier; Patrick R Schmidlin
Journal:  Dent J (Basel)       Date:  2018-10-20

6.  Influence of adjunctive azithromycin on microbiological and clinical outcomes in periodontitis patients: 6-month results of randomized controlled clinical trial.

Authors:  Katarina Čuk; Katja Povšič; Suzana Milavec; Katja Seme; Rok Gašperšič
Journal:  BMC Oral Health       Date:  2020-09-01       Impact factor: 2.757

7.  Effects of Erythromycin on Osteoclasts and Bone Resorption via DEL-1 Induction in Mice.

Authors:  Hikaru Tamura; Tomoki Maekawa; Hisanori Domon; Takumi Hiyoshi; Satoru Hirayama; Toshihito Isono; Karin Sasagawa; Daisuke Yonezawa; Naoki Takahashi; Masataka Oda; Takeyasu Maeda; Koichi Tabeta; Yutaka Terao
Journal:  Antibiotics (Basel)       Date:  2021-03-17

8.  Use of amnion-derived cellular cytokine solution for the treatment of gingivitis: A 2-week safety, dose-ranging, proof-of-principle randomized trial.

Authors:  Hatice Hasturk; David Steed; Emre Tosun; Melissa Martins; Constantinos Floros; Daniel Nguyen; Danielle Stephens; Maryann Cugini; Jacqueline Starr; Thomas E Van Dyke
Journal:  J Periodontol       Date:  2021-05-06       Impact factor: 6.993

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.